The Impact of Antipsychotic Dose Reduction on Clinical Outcomes and Health Care Resource Use Among Medicare Patients with Schizophrenia

BACKGROUND: Antipsychotic medications are used to treat schizophrenia and may be associated with adverse effects, including tardive dyskinesia (TD), following prolonged use or upon changes in dosing regimen. OBJECTIVE: This retrospective analysis evaluated the burden of antipsychotic dose reduction...

Descripción completa

Detalles Bibliográficos
Autores principales: Zichlin, Miriam L., Mu, Fan, Leo, Sam, Ayyagari, Rajeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481169/
https://www.ncbi.nlm.nih.gov/pubmed/34480726
http://dx.doi.org/10.1007/s40261-021-01060-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481169/
https://www.ncbi.nlm.nih.gov/pubmed/34480726
http://dx.doi.org/10.1007/s40261-021-01060-3

Ejemplares similares